KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Health authorities in the Democratic Republic of the Congo began administering Ebola vaccinations in Kisangani on Thursday, launching a targeted campaign in the capital of Tshopo Province to protect frontline responders. The initiative prioritizes healthcare workers, emergency response teams, and individuals with direct contact with confirmed patients as the country confronts its deadliest recorded Ebola outbreak. Health Minister Samuel-Roger Kamba confirmed that the government deployed an initial supply of the Ervebo vaccine under a compassionate-use framework across impacted eastern provinces to safeguard essential personnel and help disrupt viral transmission chains.
Official data from epidemiological sources reveals that the outbreak has affected six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Statistics published by the Ministry of Public Health and Prevention show that the country has reported 5,713 confirmed cases and 2,744 deaths. The case fatality rate among confirmed cases currently hovers around 48%.
In response to the health emergency, international agencies, including the World Health Organization, have stepped in to support local medical teams with logistics, laboratory testing, and vaccine distribution efforts. Authorities are administering the Ervebo vaccine under a compassionate-use protocol while researchers observe its effectiveness against the regional viral strain. DR Congo has launched an Ebola vaccination campaign with health workers intensifying ring-vaccination strategies around infection clusters to halt transmission.
Health Ministry Allocates Ervebo Vaccines Primarily to Kisangani’s Medical Staff
Operational challenges for logistics persist due to regional infrastructure complexity, ongoing security issues, and high population movements across border districts. Cold-chain systems have been established in Kisangani to ensure vaccine integrity at ultra-low temperatures before reaching remote health zones. DR Congo initiates Ebola vaccination activities as civil defense and community health workers conduct outreach to bolster disease surveillance and reporting mechanisms.
Epidemiologists from the Africa Centres for Disease Control and Prevention are collaborating with local response teams to monitor adverse reactions and assess immune responses among vaccinated populations. Officials highlighted that early detection, combined with isolation procedures and supportive treatment, remains crucial for improving patient survival rates. Additional vaccine shipments are planned as distribution expands to secondary health districts regionally.
Authorities Reinforce Infection Control Measures in Treatment Facilities
National teams are intensifying contact-tracing efforts across urban and rural zones in the eastern territory. Local health centers are receiving protective equipment, diagnostic reagents, and therapeutic supplies to enhance preparedness. The government has affirmed that comprehensive public health actions will stay in place until viral transmission metrics indicate a consistent decline across all affected provinces.
The government urges communities to fully cooperate with mobile vaccination units and to follow established sanitary protocols. It is expected that increasing vaccination coverage among high-risk populations will help stabilize infection rates in the upcoming weeks. Surveillance networks will maintain heightened monitoring at transportation hubs and borders to prevent further spread.